1.

'Uurl!f.lNt1~ll!hHn:i'l.h:;'l!l.I The18th IFCC-FECC European Congress of Clinical Chemistry and Laboratory

Medicine (EUROMEDLAB INNSBRUCK 2009) 'tl'I.h(J~l'W~~~fiv International Federation of Clinical

Chemistry and Laboratory Medicine.;

Nt1~1l!1'J'8~Antioxidant and Pro-oxidant Activities of Black Rice Pigments on Blood Cells and on Lipid

Metabolism Gene Expression of HepG2 Cells

7 llt.!'WlrJ'W 'Vi.fl'. 2552 5

jltJ~l'U fllj'Uth:;1£J.l lilJ.lJ.lUl

2. jltJt1:::!6tJ~flljth~1£J.lJilJ.llJ'Ul

u iI ..I v 'V v 'I ' <V iI ,2.1. 'YI1'tlfltn'J'lJ'J'::'ifJ.lhmJ.lUl ('YI1'tlel!'YIWUt1::Ml'tlfltJem)q u

111"'fllMtY: The18th IFCC-FECC European Congress of Clinical Chemistry and Laboratory Medicine

Congress of the Austrian Society of Laboratory Medicine and Clinical Chemistry

- LAHORA TORY DIAGNOSTICS - LESSONS FROM CLINICAL TRIALS AND EPIDEMIOLOGICAL STUDIES

- GLICOMICS - STATE OF THE ART

- THE STRESS RESPONSE AND INTRACELLULAR SIGNALLING

- THE ENVIRONMEl'<"f AA'D LABORATORY DIAGNOSTICS: NEW OP.PORTUNlTIES AND NEW DUTIES

- PHARMACOGENETICS OF ANTIDEPRESSIVE DRUG THERAPY

- DIAGNOSTICS IN THE GENOMIC AGE: DOES ANYONE KNOW WHERE WE'RE GOING?

- LIPIDS AA'D LONGEVITY

- CONSIDERATIONS FOR THE TRA.l\JSLATION OF PROTEOMICS BIOMARKER RESEARCH INTO ROUTINE

IN VITRO DIAGNOSTICS

- UL'fRASENSJTIVE CARDIAC TROPONIN ASSAYS - DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION

ANDBEvOND

- BIOMARKERS FOR DIAGNOSIS, RISK STRA TIFICA nON AND GUIDANCE OF THERAPY IN PULMONARY

EMBOLISM

- FROlll'TIERS IN CLINICAL TOXICOLOGY

- NEW ANALYTICAL FRONTIERS IN CLTh'lCAL TOXICOLOGY: THE ...OMJCS COME INTO PLAY

- EXPERIMENTAL FACTORS INFLUENCING SELECTION OF DECISION LIMITS FOR CARDIAC TROPONIN

- PROGNOSTIC SIGNIFICANCE OF DNA METHYLATION MARKERS 11'1TISSUES AND CORRESPONDING

CELL-FREE

CIRCUL.ATL'IG DNA IN PLASMA OF NSCLC PATIENTS

- VITAMIN D METABOLITES A.T\'DCARDIOVASCULAR DISEASE: NOVEL EVIDENCE FOR PREVENTION

- CARDIAC CELL THERAPY: CURRENT EFFICACY AND MONITORING ISSUES

- TISSUE ENGINEERING APPROCHES TO ENHANCING OR ENACTIN CELL THERAPY

- MULTI-MARKER APPROACH WITH THE USE OF BJOCHIP CARDlA.C ARRAY TECHNOLOGY FOR EARLY

DIAGNOSIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES

- EARLY DIAGNOSIS OF ACUTE CORONARY SYNDROME: ARE WE MEASURING THE RIGHT MARKERS?

2.2 ~!.uli·nnh~'1IuI tTUU'iH (1ln!lU 11h~!l1ftciJilciJ) !!tI~~tI!!1J1JfI1~ll~lh~'lluf mmm

~t~Th:Ulh~"lt:Ul}j~:IJ1tu 1,000 nu mn 80 11l~ti1f1' u~~1~tllU1J1Jflld1Jddl'l1fJ eHml1:U 1~wlilI'l11'{)~lln:'1f:lJl'/ mfJ'li'u.:j h!!1m l~fJlfitJ 1I'lfJiJ'Hmtl'l11~fl 111't~flflfll:Ufl11lJfftJ i'll'\lfl~N! ;Jli 1lJlld~"lflJ

q •• q

iJfl1dtff'UmHl,ntJl'Utllu1J1Jl11fflflfl{~~I'l!tI~fJ'UfitJitllJfl 21tJ 1'W 3lftJ~ ~fl1J~ntudfl1J '1 Congress~ 'jJ do A ~r::!.d .00. Q,I t

Center ''If'U2, Gothic Cellar.tmz Baroque Cellar nlJU(;l1lJ'Ill'W1'W 451 tdtl.:j 'Utlfl'illfl'WfllJ1JJ'!fYl\9l1~'l :IJ1I $I 1 :iJ J

~ c:. .do .::9. •• I tI 0 ..di 9J .Q tI ~ ..:"! dl1Jl'ltJi1nf1'fll':i tf!':iU,,'llJV ~1JfldW lm:;:;'U11'J1i1 'li'\9ld11li11~1l'lI'J1f1'lff\9l':iflldU'YfYlI'J 'Htlll'J'VI'Wi1'\lV.:JCongress

Center, Pavillioaltmz 2 AFlfl!1JFltt!;W]-rYlfl1'W•

mlUn1U&~fnft'Ut)n1J':i':im£ll~fJH1J':i'WlfJ1'U&~tlJ (fJm~fJijfh-3~t)mlllf~UltTl!';))... .. ..<r jJ OJ t:::. 0 d

fll';i1J'J':iflltJ t\9ltJJ;j1J';i';itJ11'J';itll'li'ty Professor Dr. M. J. McQueen l'l1~1'Ui1 Department of

Laboratory Medicine, Hamilton Health Sciences, Department of Pathology and Molecular Medicine,

McMaster University, Hamilton, Ontario, Canada 'lJ'j',jfJlfJ'1'W!~{).:J LABORATORY DIAGNOSTICS -

LESSONS FROM CLINICAL TRIALS AND EPIDEMIOLOGICAL STUDIES '1i'ml11fi~fI11:JJi:hflW"

..11'WltJl'Jfl ..11'Wlt1fl11lJt~U>1l9itl1 dfl t~fl 'l4f'l'IJfll5 rmnfl'W '~tlcil~li1l5:;:;if'YIifl1'V1 UCl~!f1tltl5~W'Wfl11:JJ

U~.:jm .:jfflJ'lJ':iW'\liJ>1~1>1flltJ 111ms \9l),,)~'Yl1.;j11'iJ.;jtlijiJ~flwvm ms U'VI'YIcJl ~iJfl1 5 n\PJJ'Wl mh'll9imrltl'l

lit. I "." =.... l' ~"'" gJ lq'" gJ '" i.9 v t9 vt1J'VI':ifllJfl1Jflld1'il1'Ji11,,'1\>11'Wflldt'IWlfl1Jfl'W 1'\JU~~\9l1'W':i~1J1~TVW1'\J{).:j ':ifl "li'lflfl,,'lCl.:jl'J'Wi;!~lJ1fl 'il~mN

d Q.I 4 ~ Q.I 91 c::\: 0 d d9 51 1 .:ufll'n::;~lJlJ'W 'illfl.fl1m!Ui:l:;Wfl~'U"li'lt 1J'U'UflCl.:jlJ'Wi11'll'll'W fllJHCl\9l 'WlCllfflt s 'Il~tli11 'lffl ':i1'il d fl\911'l '1

tll'il ..11'111'.fl1i'1r! ~tl>1r umse '1'Wfl1 5 ~ltJfhf flEJ1'VW11J11:li;!'l~'W Ul9itill 'tm-3r;rVi fJlm1H'I~fil H~ lfJl:l-3'1'U

2

oJ ••

~1'Um'a~m:ITVWl1l1i;\ 1)1f)m'jf1mn111fJ'I'1l.:j~1'U11'Ullm'jlJ'\lfN'lh~~1f)';if)~1l~l\l ~ 11,rYiliinlt1Ut'l::::

tnf)'il'Un'IJm'j!n~ IHI ~U~a~l~mn~ijm'.i~fl'IJ~'Ufl\l~e)f)1)ff)lJ1H\9lf)~l\1n'U trlfl1~tIl'lfil~l~tJ1n'W ~~

e 151 '" ee 1 '" '\' d", "'''' 0' '1 lq '" qm 'l1~fl.:jlJThis national and international guidelines 'Umnm:n tnll'lll~'IJ~f)1'jill~\ll~'W 'jA t'llll'W t'W~ d UJ d. QI , d'& y e;S Q.I ~d. .d

l(jfl~tH 11l1'1111'WlJ::::1Hhfl'l11 l'11ua::;1'iM~m{)~ 1'Wmnmn hAl'l1m'U'il'l~tJ\llJf)l'J'YjWJ'W1J1i~'jl'il'Vl••11f~l'ltJf1l11fl\lHl.i'WihHa::::'J1~1~1lvltlmllYilhJnllm'j~m111~CJ1it:ni'm:l1~ l~rlfttlf1nml'W 1.fi ~\I'th1M'~ ~. ~

," "l'l ';i ll1U.;J1~ ms ~ ':i1'ill~tlf)l'ai' rnn 11f1l9ifl'Illf1U"hJ fI-ll11fl-119ln'll~ 'Uli m 1lJ'lltJ~fI'Wi .u'n~tJml'IJfl11lJl~(FJ.

I ~, •

I9itlf1111iml'Wf)l'ji'mn hfl~l'l '1 yHlfJUN 1'i~tll~tJi''l !~tll~l$i'fH'lfmi'flfnVi~ Uj;'}~j;'}flm'j~tlJl~fJ~1\9\

. ,~ ~ Vv ~~~- '!il£J-31'U!ft£Jdfl'IJfll'mI"WBfH'I-3m'\lB-3m'U'YI'U!m~f1!;1'Y1 &~1'U

'U •

Y-li;\-11'U~UmY'WflhntJhJlllflfl{ltlfl'~ ~~'WlllmBl'W '~i'U1'U~ 10-11 ilU'UlfJ'U"'.. .1l€l~'lh'ln€ll 13.30-14.30 Umn..!tl1flm~1'llfl·::H:-laHU111fJirfi1')fJ~~'U 'hii'W~1'\11!~£nn'U~m'Yj~f1t1

•• q

~ ... td J::::i G .& QI QI .d 0 lit d 9l 1 dQ.J 4

!l'HJ1!t'lmuM'WmllJfI~t1'iWli'lf1'UU1:l::::f1'Uf-lj;'}\ll'Wl'l'Ult'lh~'UfllJN~'W llmfl'YjtJ~lJm'j 'Wflf11J1f1'W(J\llJ'"

1t1m19lflf'l11f1'J!f1111V'lh::::!'VlffI9iVJ'1 ~1'U1'U'J1lJUti'1450 l~fl--11~fJ,)~!lff~-1u'l.i\l19l1lJi1'li'tl\9h--1"l flllJ

"ffl'\ll~mt "l i\lu Aging, Autoimmune disease, Blood banking and haemovigilance, Bone

disease and vitamin D. Coronary artery disease /ischemic damage, Cardivascular disease:

heart failure/hypertension, Cancer and tumor markers, Clinical importance of laboratory

testing. Clinical care testing. Diabetes mellitus, Fertility, Genetics, Haematology,

Haemostasis, Immunology, Immunoassays, Infectious diseases, Information technology,

Inherited and acquired metabolic diseases, Iron metabolism/haemochromatosis. Kidney

disease, Lipid and lipoprotein, Liver and gastrointestinal diseases, Mass spectrometry,

Metabolic syndrome, Metabolics, Molecular diagnostics, Neonatology, Neurodegenerative

diseases, Nutrition, Pediatric clinical chemistry, Pharmacogenetics/Pharmacogenomics,

Point of care testing. Proteins and proteomics. Quality assessment, Reproductive

endocrinology, Rheumatology, Stroke, Technology information and methods, Thyroid

function. Traceability and standardization, and Miscellaneous, . .

'" '" "-' '" I ,,~ !II !II I _I '"- fldllJ!l1lA!t1£J1t11Jfll'!inf'U6f1'Q~l'U'YI'UltI"Wt\l!OOfj!'\I1"J1lJlJ''j~'iPJfI'Utl'U1

, I Jl" ,

mHl'U111tJ'\ItJ~~l ;)lj1lJ1.h ::::'!PJ~mB'W'1tAl~'U 1'i11'i1:l1m~tJ\I;1~Viih l'U11tJ\Ilf1ti'lfiMl'1f'U11tl~

- THE ASSOCIATION OF LIPID AND ANTIOXIDAl"IT PARA..'VIETER VALUES IN AGE-RELATED MACULAR

DEGENERA nON,

3

- CORRELATION OF URINE AND SERUM ANTIOXIDANT CAPACITY AMONG YOUNG A~"]) ELDERLY PEOPLE,

- THE AGE-RELATED OXIDATIVE STRESS INCREASE IS ACCELERATED BY SMOKING HABITAND OBESITY,

- FREE RADICAL SCAVENGING ACTIVITY OF GREEN TEA AND ITS EFFECT ON BLOOD GLUCOSE AND LIPID

LEVELS IN DYSLIPIDEMIC SUBJECTS,

- ANTIOXIDA..1\'T EFFECTS OF LYCOPENE AND UBIQUINOL-IO ON THE OXIDATIVE STRESS IN RAT

HEPATOCYTES INDUCED t-BUTHYL HYDROPEROXlDE,

-INFLUENCE OF DIET RICH IN ANTIOXIDANTS IN URINE AND SERUM AI"ITIOXIDANT CAPACITY,

- TISSUE MALONDlALDEHYDE, NITRIC OXIDE, GLUTA TIDONE LEVELS AND SUPEROXIDE DISMUT AS.E

ACTIVITIES OF PATIENTS WITH BLADDER CA-NCER,

- RELATIONSHIPS BETWEEN AJ'''TIOXlDAA'TS A-NDLIPID PEROXIDA:r..'TS A-NDTIlE RELATED GENOMIC

POLYMORPillSMS IN PATIENTS WITH UPPER AERODIGESTIVE TRACT CA-NCERS,

- EFFECT OF ACETYLSALICYLIC ACID ON PARAOXONASE ACTIVITY AND OXIDATIVE STRESS,

- EVALUA TION OF CIRCULATING MALONALDEHYDE AND APOLIPOPROTEINS LEVELS IN TUNJSIAN PATIENTS

WITH MYOCARDIAL INFARCTION,

- STUDY OF ANTlOXIDA-NT AND GENETIC MARKERS IN CHAGASIC PATIENTS

'WVfl'i11fl.nV.:jiinwl<itl1'Wt~V.:j~l~(r;lfillf11'j'1h'YIflUfll!ml~l1'!t1l1l1'i1~"1 ml~m'jH;t9i't1~

'Ifi!~fil.:j "1 d~Vfl1'j1~fJ ~'H)l'i1'i1~'\.'hlJ11oMltI'WUll11'Y1~1;H)111'W.:jl'W1<itlliitJ1'l1

i'))'" '))." 91'" " "1'))'" '" q 91 1 191f'l'JllroJ'Wl'fl11lJl'YI1~1'1f1f11'j~1'W1'Y1t1lf'llbY~1f11'jU'Jll'YIU 11'Y1'WbYlJUt'WI1BlU"1 ~1'W ~(J 'If

Q.I:: I oC::I.' I .& 91 - ~ QI ~ , OJ i31)n(lltlt.!1:1'Wfll1m'j'~Y;)~llJtl1t.!lTfflSl1mU"1I"lJ 9i.:i~V.:iSm)fl'Wl'WllCl:;fJ.:i tllbYllJl1tl9iflmll ~ !~tI~H

'WVfl111fl.nV.:J'1?1111'W!fl~v.:jrivl'Y1lnft1bY~{tw im.i "1 ~Ei.:jlJl '~U.:j!ri{N i'YICl

,3. lX'nJ'li'6ftvUlhmil~'lh:;:1tJ'tl'itmv\'1'mnf)fll'j'lhh:;:'nJI tT'mJt.!l'H~eu;r'l-le~il~l'l-l

q ~

!U !U!U "" I3.1 Vll'l-lfllUlflll'tlUl'flHl'tl'lfll'j I. .,flJ111iYiil?1111i1i oM~roJ'Wl.:il'Wl<i (j u t;l~~1'Wrm~l'W ms (1Cl'Wf11':ibYVU'llV~ fllfll'1f1 i'l1-.1' 'WmjawB 'l 'l1

"L~ d '" d 91 OJ "" OJ 'I d ~ bj 91 0 31", '"fl1~11ft'l t'fIU~ m ll~IThI ftl1lJ fI~!l1l.1Ht1Q:;fnlJJ ~'illfll.l fl1,HJ tl.I~1'IJ1'Ylt1"Wt'il!'Y'l11::::tYl'Yllfl11:lJ ~ 'i)f)fl'lJ

mnClrh '1-1i'W~1'Wci'3.3 ~1'1-1UU1nHm'juflifw'l'il.,

i~f11'Y1 ':i111TI f11nhnw 'llV":l'Irfll'1fl f111tm Errh'W f11rr:hmulH l.I1flfllllflvi ll.llJllJ f11ufi'1JtyI11~

lJ irl~(nmrfl

4

.3.4 NilA6!'iltl'Hllflfll"j"lhh:;:'tl'~I tT'~~Ul'H~tl 1'j'1.hUU6e.JiJ,:nU(Ulib

q

1$1f1JrJ~1t~~.•nn if u E~hni"l ~~'j)~ 'l$lih irnl 111111\l1J'Vl!~vu~H'CI'{)uiJ i191 u~~lllm'fil'Jj U1~1'Ul~vlift! ' lIj 'Ii "" 91 ~ <V _ 1 •.• '" lij 91 C;;, 91 '-"I~ t,ll:l'lf1&'l llPlt'wUt,nu lUf)l'J'ilYl1J'J~'l.l'lJ'J~Yl11U1U1'lfWllW~ ~fl'W1J!'I1U{)1fl1dl'l1\1"l {)1~'I1mtJ'J{)tl1J

'Ut]j{)\I~lflum\Plf) 11:'1f) ua~'~rI-!I!'Wa\l Classic ,.h~iui'l\Pl{J Mozart f)1!tlf)'tl{)\l1amllf)t!';j~t'Vlrr

" "{){)tn91jtl ~!~u${ufhl'UYI ~~~Yl':llullj~'l!llllm1"wtJ Symphony Concert 2 fl1'1iu'H{)1I)~'l!1l lH;)~

Organ Concert 1 flr'li'U 11J'((f,1!fhWl Dome St. Jacob ml\11l1f11l1Jf)l'jl.h~'l!1l'Vll-!l1'lflf)ljl!~1:'1::;1'W ~\I

'kht!'J:::Yl1J111HI9i{{l'Hlm~'Wf)lj~\Pllut!j::;l'V\rrl'Vltl t)1~ljE\I'iJ1t1\1111illtl1\Pl'lfl1I9il\1'lfl~l~lht~i)'W

"1l'V/l1'Vlm~tI'Illll::;1J'I!1Ja''W'W~ll\ll'l.,(J~tIi'Wfl1),' tJ'lh::;'lf1l1'lflf)l)''j::;~1J'W l'Wl'lfl~' ~mf)f)':hi1. .U'iJ\Pl\lffmJ.fl1'Yf'tltl\l1h:::!'Vlrr1'Wf)l';jll)::;'lflJ'j ::;~1JUl'Wl'lfl~ 'WltJ1JlCJ!~ll'tltl\lm-n"l 1'11' t!f11~V'CI'llll'HJ111

• q

.11.., I v~ v.... ~_I_I <V '" 15. ~j'U'fJ'Wll:;:!f.Jm1't'ijmnl~n ~~j'Umflm'j mlJj:;:~:U/ iI:umn 'V/jel!iI'Wtlf.J(;1-HIJP1t1fl1';J

[ / ] 1Jddtnt:J [ ] ~lllJ'Wl

~ dQ d"GJ G).dI Q.1 ~ 4

[ I] tl'W"l 'J:::'4..." .... ~'I~'Yfll'W !'W11'J1Jl'J.f11Vru 6 lfltl'W'l'/t'l-!l'illf1tllll'J~'l!ll'l1'Jtl!'iJ'Wtlfm~l'W U~::;

'il::;)l(J\llWHlfllj~hliJ'W\ll'W illif\l~htl1'151f)l'j .f11Cliu 1 t~tl'W'l'/i:l\lf)l'jlrWUl'dml11i

"--'-.

5

.......................................................................................................................................................

........, ,.~ '" '" .

mfl1ifl'\l~i1'irmn:!u 'TI~i'm:rW!fmuVi'ifrJl:ui~ ~i''lJ'illf1m'J ilhhg;'\f:u/ rl'lJlJUll1~B!UUBy.HN1U ml,J'illf1

mr hhh:::'\fJJHtI:::lfflHlfHl"Jl'WU-&'1

~~~?// cv ~ ~

.......................... '" 'H1'H'W1Jllfl1"lfl

"" 0 0'

( f.lfl'.~J.!'Yl1'Wl'YlUfllLU11 )- """. ...• ......•.:J 0 "\ J . V r: .!->--' "C..-........ .I..o'!..: .I. .

~ ~ \7. rrm.l111'Wflll.!'lJr1 ~! j \ , C\

"S r. «> \\. ...---t{ ~ i g. (! I ~ r-.........., P.~ 5..0":!.!:-.l!J.a:!.~ .~R~'1'.Rlrl 9~~ .;;. ).::.!j.n .~.E.1Y..0!.~].i.f:'!.]l ~\0.':J. ~ .~.f.Lf.4 :9 j

'" J-1.W.~. !Y.G.)).~ J.n .\Y.'!. .. ~ ..~ ~!::'.:'J.:!'..'" .v. .•• •• r ••••••• ~ ••••••••••••••••••••••••••••••••••••••••••• " •• *. . . .. . .. .. . .

.. ........... '" ................................................ . ,"" ~.

/l.................(}!:~:,............. flll.!'lJ~

= '" 0'( Vlft. ~d. lUl'll ~U'l"i'l"i'J'l"i'U~)

....1./. 0.;..0 I. J.~L-

6